\-\ Texto\\:\\ \ \(0\)\
\-\ other\\ than\\ the\\ reported\\ rupture\\ of\\ the\\ right\\ tympanic\\ membrane\\,\\ there\\ are\\ no\\ pertinent\\ physical\\ findings\\.\ \(0\)\
\-\ because\\ there\\ was\\ no\\ definitive\\ evidence\\ of\\ bone\\ erosion\\,\\ antibiotics\\ were\\ continued\\ with\\ the\\ plan\\ of\\ follow\\-on\\ imaging\\ of\\ the\\ right\\ mastoid\\ if\\ complications\\ are\\ suspected\\.\\ \\ therapy\\ for\\ lymphoma\\ continues\\,\\ and\\ future\\ pet\\ scans\\ of\\ this\\ patient\\ are\\ likely\\,\\ allowing\\ for\\ evaluation\\ of\\ resolution\\ of\\ the\\ mastoiditis\\.\ \(0\)\
\-\ images\\ taken\\ from\\ a\\ pet\\/ct\\ exam\\ demonstrate\\ opacification\\ of\\ the\\ right\\ mastoid\\ air\\ cell\\ without\\ evidence\\ of\\ osseous\\ erosion\\.\\ \\ there\\ is\\ abnormal\\ metabolic\\ activity\\ \\(suv\\ \\=\\ 7\\.3\\)\\ at\\ this\\ site\\.\\ \\ also\\ noted\\ are\\ areas\\ of\\ abnormally\\ increased\\ metabolic\\ activity\\ in\\ the\\ left\\ anterior\\ cervical\\ nodal\\ chain\\,\\ both\\ supraclavicular\\ regions\\,\\ in\\ the\\ prevascular\\ space\\ and\\ the\\ right\\ internal\\ mammary\\ chain\\ consistent\\ with\\ the\\ patient\\'s\\ known\\ diagnosis\\ of\\ hodgkin\\'s\\ disease\\.\ \(0\)\
\-\ acute\\ otomastoiditis\\ \\(non\\-coalescent\\)\ \(0\)\
\-\ acute\\ otomastoiditis\ \(0\)\
\-\ coalescent\\ mastoiditis\ \(1\)\
\-\ lymphoma\\ infiltrating\\ mastoid\ \(0\)\
\-\ 19\\ year\\ old\\ male\\ with\\ history\\ of\\ stage\\ ii\\ hodgkin\\'s\\ lymphoma\\.\\ \\ the\\ patient\\ had\\ this\\ pet\\ scan\\ ordered\\ to\\ assess\\ response\\ to\\ chemotherapy\\.\\ \\ once\\ the\\ scan\\ was\\ complete\\,\\ the\\ additional\\ pertinent\\ history\\ of\\ a\\ recent\\ perforated\\ tympanic\\ membrane\\ on\\ the\\ right\\ was\\ obtained\\.\\ \\ according\\ to\\ the\\ oncologist\\ taking\\ care\\ of\\ this\\ patient\\,\\ the\\ patient\\ was\\ taking\\ antibiotics\\ due\\ to\\ the\\ tm\\ rupture\\.\ \(0\)\
\-\ it\\ is\\ not\\ unexpected\\ to\\ have\\ fluid\\ in\\ the\\ mastoid\\ after\\ perforation\\ of\\ the\\ tympanic\\ membrane\\.\\ \\ the\\ significant\\ metabolic\\ activity\\ of\\ the\\ right\\ mastoid\\ \\"raises\\ the\\ bar\\"\\ of\\ suspicion\\ that\\ this\\ process\\ is\\ active\\ and\\ could\\ become\\ coalescent\\ in\\ the\\ future\\,\\ necessitating\\ continued\\ surveillance\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mastoid\\:\\ 0\\.0888754174342215\ \(0\)\
\-\ tympanic\\:\\ 0\\.05977994467107042\ \(0\)\
\-\ membrane\\:\\ 0\\.05424753719346042\ \(0\)\
\-\ otomastoiditis\\:\\ 0\\.052029462177129226\ \(0\)\
\-\ coalescent\\:\\ 0\\.052029462177129226\ \(0\)\
\-\ metabolic\\:\\ 0\\.04570828780323367\ \(0\)\
\-\ mastoiditis\\:\\ 0\\.04363126138430842\ \(0\)\
\-\ chain\\:\\ 0\\.04166784105590668\ \(0\)\
\-\ hodgkin\\:\\ 0\\.038404410559566914\ \(0\)\
\-\ activity\\:\\ 0\\.034722526665504024\ \(0\)\
\-\ pertinent\\:\\ 0\\.03471613890782691\ \(0\)\
\-\ future\\:\\ 0\\.03420924895350743\ \(0\)\
\-\ taking\\:\\ 0\\.0327714967866458\ \(0\)\
\-\ pet\\:\\ 0\\.03238111973776294\ \(0\)\
\-\ non\\-coalescent\\:\\ 0\\.031824976259806854\ \(0\)\
\-\ erosion\\:\\ 0\\.03116035201181396\ \(0\)\
\-\ follow\\-on\\:\\ 0\\.027858866914434614\ \(0\)\
\-\ continued\\:\\ 0\\.02656837535679593\ \(0\)\
\-\ lymphoma\\:\\ 0\\.026449804704579267\ \(0\)\
\-\ rupture\\:\\ 0\\.026195903379969264\ \(0\)\
\-\ prevascular\\:\\ 0\\.025356530522521455\ \(0\)\
\-\ 7\\.3\\:\\ 0\\.023512394696651454\ \(0\)\
\-\ necessitating\\:\\ 0\\.023512394696651454\ \(0\)\
\-\ antibiotics\\:\\ 0\\.023174847347801453\ \(0\)\
\-\ bar\\:\\ 0\\.023168314625155697\ \(0\)\
\-\ oncologist\\:\\ 0\\.022854194130608296\ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.022048621743192377\ \(0\)\
\-\ mammary\\:\\ 0\\.02181563069215421\ \(0\)\
\-\ raises\\:\\ 0\\.021596769241553366\ \(0\)\
\-\ suv\\:\\ 0\\.021195232652707792\ \(0\)\
\-\ nodal\\:\\ 0\\.020665978233242534\ \(0\)\
\-\ tm\\:\\ 0\\.020665978233242534\ \(0\)\
\-\ unexpected\\:\\ 0\\.02050550255609151\ \(0\)\
\-\ \\'s\\:\\ 0\\.02040483702202576\ \(0\)\
\-\ allowing\\:\\ 0\\.01992664822369014\ \(0\)\
\-\ right\\:\\ 0\\.01952992871719314\ \(0\)\
\-\ perforated\\:\\ 0\\.019202205279783457\ \(0\)\
\-\ surveillance\\:\\ 0\\.019202205279783457\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.01898978470208334\ \(0\)\
\-\ plan\\:\\ 0\\.01888808478523606\ \(0\)\
\-\ this\\:\\ 0\\.017349047171735254\ \(0\)\
\-\ scan\\:\\ 0\\.01727271812586988\ \(0\)\
\-\ according\\:\\ 0\\.017166337232563462\ \(0\)\
\-\ abnormally\\:\\ 0\\.01698427638914508\ \(0\)\
\-\ are\\:\\ 0\\.016821283357828183\ \(0\)\
\-\ infiltrating\\:\\ 0\\.01675498611577928\ \(0\)\
\-\ opacification\\:\\ 0\\.016335953006563566\ \(0\)\
\-\ \\=\\:\\ 0\\.01619055986888147\ \(0\)\
\-\ evidence\\:\\ 0\\.016176480746331247\ \(0\)\
\-\ continues\\:\\ 0\\.016096785549736127\ \(0\)\
\-\ suspicion\\:\\ 0\\.016005385520911974\ \(0\)\
\-\ perforation\\:\\ 0\\.015872483090866064\ \(0\)\
\-\ once\\:\\ 0\\.015786524070311125\ \(0\)\
\-\ patient\\:\\ 0\\.015461948211487147\ \(0\)\
\-\ assess\\:\\ 0\\.015461801194271632\ \(0\)\
\-\ response\\:\\ 0\\.015461801194271632\ \(0\)\
\-\ definitive\\:\\ 0\\.015236095934411222\ \(0\)\
\-\ acute\\:\\ 0\\.015233785769721987\ \(0\)\
\-\ become\\:\\ 0\\.014695257384849272\ \(0\)\
\-\ ordered\\:\\ 0\\.014511652990504538\ \(0\)\
\-\ scans\\:\\ 0\\.014365474790667944\ \(0\)\
\-\ was\\:\\ 0\\.014271155555432301\ \(0\)\
\-\ 19\\:\\ 0\\.014224985923340603\ \(0\)\
\-\ regions\\:\\ 0\\.014116403052447902\ \(0\)\
\-\ there\\:\\ 0\\.013773092669295906\ \(0\)\
\-\ resolution\\:\\ 0\\.013305486314236191\ \(0\)\
\-\ ii\\:\\ 0\\.013305486314236191\ \(0\)\
\-\ suspected\\:\\ 0\\.013284187678397966\ \(0\)\
\-\ stage\\:\\ 0\\.013158969057503056\ \(0\)\
\-\ osseous\\:\\ 0\\.013097951689984632\ \(0\)\
\-\ site\\:\\ 0\\.013037948508627085\ \(0\)\
\-\ taken\\:\\ 0\\.012863700346281114\ \(0\)\
\-\ additional\\:\\ 0\\.012369843661191326\ \(0\)\
\-\ complications\\:\\ 0\\.012224450523509232\ \(0\)\
\-\ process\\:\\ 0\\.01187749272503507\ \(0\)\
\-\ active\\:\\ 0\\.011778190754674659\ \(0\)\
\-\ the\\:\\ 0\\.011479182484416582\ \(0\)\
\-\ could\\:\\ 0\\.011381075609496579\ \(0\)\
\-\ reported\\:\\ 0\\.01124575758330618\ \(0\)\
\-\ cervical\\:\\ 0\\.011209716269283859\ \(0\)\
\-\ care\\:\\ 0\\.011126993310717518\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.011057566011338863\ \(0\)\
\-\ obtained\\:\\ 0\\.010967025634454303\ \(0\)\
\-\ complete\\:\\ 0\\.010856952830274566\ \(0\)\
\-\ because\\:\\ 0\\.010792484897422556\ \(0\)\
\-\ air\\:\\ 0\\.010437771214989048\ \(0\)\
\-\ areas\\:\\ 0\\.010380314697639231\ \(0\)\
\-\ recent\\:\\ 0\\.010370826891118401\ \(0\)\
\-\ internal\\:\\ 0\\.010342512171042496\ \(0\)\
\-\ space\\:\\ 0\\.010204176920854277\ \(0\)\
\-\ known\\:\\ 0\\.009761917272432563\ \(0\)\
\-\ evaluation\\:\\ 0\\.0089611508874614\ \(0\)\
\-\ abnormal\\:\\ 0\\.008798166932544807\ \(0\)\
\-\ \\,\\:\\ 0\\.008795633897673596\ \(0\)\
\-\ fluid\\:\\ 0\\.008767650197125824\ \(0\)\
\-\ likely\\:\\ 0\\.008701407819262298\ \(0\)\
\-\ history\\:\\ 0\\.008521404604383274\ \(0\)\
\-\ if\\:\\ 0\\.008370914923395796\ \(0\)\
\-\ cell\\:\\ 0\\.00833299895877793\ \(0\)\
\-\ significant\\:\\ 0\\.008295477079618136\ \(0\)\
\-\ therapy\\:\\ 0\\.008247800708449866\ \(0\)\
\-\ due\\:\\ 0\\.008232047483584259\ \(0\)\
\-\ than\\:\\ 0\\.008083208862520844\ \(0\)\
\-\ anterior\\:\\ 0\\.007945100446796886\ \(0\)\
\-\ both\\:\\ 0\\.00787797830572607\ \(0\)\
\-\ to\\:\\ 0\\.007708810621714553\ \(0\)\
\-\ bone\\:\\ 0\\.007665829174945379\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.007581714937298979\ \(0\)\
\-\ physical\\:\\ 0\\.007568611081520716\ \(0\)\
\-\ consistent\\:\\ 0\\.007564253678090986\ \(0\)\
\-\ increased\\:\\ 0\\.007546876468590815\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.007435918779719289\ \(0\)\
\-\ noted\\:\\ 0\\.007311989850009364\ \(0\)\
\-\ without\\:\\ 0\\.007263585438116102\ \(0\)\
\-\ imaging\\:\\ 0\\.007227703337384848\ \(0\)\
\-\ of\\:\\ 0\\.007150052756555246\ \(0\)\
\-\ other\\:\\ 0\\.0071106084790702115\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007099105203368378\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007083824298846282\ \(0\)\
\-\ were\\:\\ 0\\.007004643814765059\ \(0\)\
\-\ it\\:\\ 0\\.006934470702285259\ \(0\)\
\-\ exam\\:\\ 0\\.006777017833752845\ \(0\)\
\-\ have\\:\\ 0\\.006680281871354122\ \(0\)\
\-\ had\\:\\ 0\\.006656497542385229\ \(0\)\
\-\ findings\\:\\ 0\\.006566198324151479\ \(0\)\
\-\ after\\:\\ 0\\.006382675821693872\ \(0\)\
\-\ no\\:\\ 0\\.006212593145875827\ \(0\)\
\-\ is\\:\\ 0\\.006089791823661288\ \(0\)\
\-\ in\\:\\ 0\\.006085158557982021\ \(0\)\
\-\ also\\:\\ 0\\.006081659182924734\ \(0\)\
\-\ images\\:\\ 0\\.005917920187542795\ \(0\)\
\-\ male\\:\\ 0\\.005578359342554055\ \(0\)\
\-\ that\\:\\ 0\\.00532845028360586\ \(0\)\
\-\ for\\:\\ 0\\.005264318762763286\ \(0\)\
\-\ \\(\\:\\ 0\\.005215608131724625\ \(0\)\
\-\ \\)\\:\\ 0\\.005151896693958882\ \(0\)\
\-\ disease\\:\\ 0\\.005042373795002542\ \(0\)\
\-\ from\\:\\ 0\\.004571970083589214\ \(0\)\
\-\ not\\:\\ 0\\.004457829139862582\ \(0\)\
\-\ at\\:\\ 0\\.004179650371233332\ \(0\)\
\-\ left\\:\\ 0\\.0034516435713823636\ \(0\)\
\-\ year\\:\\ 0\\.0034516435713823636\ \(0\)\
\-\ old\\:\\ 0\\.0031586086529323274\ \(0\)\
\-\ a\\:\\ 0\\.002863536475224558\ \(0\)\
\-\ on\\:\\ 0\\.002613324954387827\ \(0\)\
\-\ and\\:\\ 0\\.0019495560187604885\ \(0\)\
\-\ \\.\\:\\ 0\\.00153788604031825\ \(0\)\
\-\ with\\:\\ 0\\.0012671932428507914\ \(0\)\
